当前位置: X-MOL 学术Mol. Cancer Ther. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Selected Articles from This Issue
Molecular Cancer Therapeutics ( IF 5.7 ) Pub Date : 2020-07-01
American Association for Cancer Research

### [Bennett et al. Page 1385][1] The EphA2 receptor is an attractive target for oncology therapeutics. Here Bennett describes the preclinical profile of BT5528, a Bicycle peptide toxin-conjugate targeting EphA2. Bennett and colleagues show that BT5528 has rapid tumor uptake and fast renal

中文翻译:

本期精选文章

### [Bennett等。Page 1385] [1] EphA2受体是肿瘤治疗的诱人靶标。Bennett在此描述了BT5528(一种靶向EphA2的自行车肽毒素结合物)的临床前概况。Bennett及其同事表明BT5528具有快速的肿瘤吸收和快速的肾功能
更新日期:2020-07-02
down
wechat
bug